ASTCT Supports the FDA’s Approval of Earlier Use of CAR T-Cell Therapy for Multiple Myeloma
The Food and Drug Administration approves CAR T-Cell therapy Abecma as a second-line treatment and the CAR T-Cell therapy Carvykti...
News
From Kids to Robots: Senzime Secures Multiple Top-Rated US Hospital Deals
UPPSALA, SWEDEN / ACCESSWIRE / April 10, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF), an industry leader in perioperative precision-based patient monitoring solutions,...
Hamilton Thorne Ltd. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Beverly, Massachusetts--(Newsfile Corp. - April 10, 2024) - Hamilton Thorne Ltd. (TSX: HTL) (OTC Pink: HTLZF), Hamilton Thorne Ltd. a...
Morris Hospital and Healthcare Centers Unify on MEDITECH Expanse
Morris envisioned and executed a “picture-perfect” Expanse implementation and go-live. CANTON, Mass.--(BUSINESS WIRE)--Morris Hospital and Healthcare Centers (Morris, IL) recently...
Inogen to Report First Quarter 2024 Financial Results on May 7, 2024
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting,...
ModMed & Medtronic Collaborate to Drive Efficiencies in Documenting Colonoscopies Using AI
The companies will work together to help save gastroenterologists time by providing real-time integration between ModMed’s gGastro® ASC and Medtronic’s...
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
Conference Call and Webcast Scheduled for 1:30 p.m. PTALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical...
Los Angeles Tourism Celebrates Global Meetings Industry Day by Spotlighting How Meetings and Conventions Benefit All Angelenos
LOS ANGELES--(BUSINESS WIRE)--Today, Los Angeles Tourism & Convention Board (Los Angeles Tourism) is proud to join our colleagues across the...
Olleyes VisuALL Virtual Reality Visual Field Testing Shows Promise in Healthy Children
The Olleyes VisuALL could alleviate limitations in testing pediatric patients and make visual field testing more accessible, cost-effective, and convenient...
Canadian Nursery Big League Genetics Exporting New Strains to German Cannabis Producer DEMECAN
Agreement is DEMECAN's first to add international genetics to its collectionPHOENIX, AZ / ACCESSWIRE / April 10, 2024 / Big...
Rocket Doctor Accepted Into Google’s AI First Accelerator and Unveils Cutting-Edge AI Patient Matching and Data Summarization Technologies
LAS VEGAS, NV / ACCESSWIRE / April 10, 2024 / Rocket Doctor, a trailblazer in virtual healthcare, proudly announces at...
Aptevo Therapeutics Provides Pipeline Update
Breast cancer patient who improved from a progressive disease diagnosis to an over nine-month sustained stable disease diagnosis has now...
PharmaCord Announces Appointment of Cindy Padgett to Chief Commercial Officer
JEFFERSONVILLE, IN / ACCESSWIRE / April 10, 2024 / PharmaCord LLC, a leading provider of patient support services for the...
Yunu Adds Pediatric Oncologist Dr. Scott Bradfield as Strategic Advisor
Collaboration aims to advance pediatric oncology trial precision with the latest imaging technology.CARY, NC / ACCESSWIRE / April 10, 2024...
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
The study results revealed improvements in symptoms and quality of life in patients with musculoskeletal pain and inflammationTORONTO, April 10,...
Joint Statement Applauding Final Rule for Web Accessibility Under Title II of the ADA
WASHINGTON, April 10, 2024 (GLOBE NEWSWIRE) -- The American Council of the Blind (ACB), the American Foundation for the Blind...
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Lack of early symptom improvement is not predictive of final responder statusMALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics,...
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Findings underscore the liver safety of AD04 as compared to placebo in the prior Phase 3 clinical trialGLEN ALLEN, Va.,...
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
MISSISSAUGA, Ontario, April 10, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will...
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that...